论文部分内容阅读
目的：研究消化酶和益生菌治疗肠易激综合症(IBS)患者的临床疗效和对肠运动功能的影响。方法选取2013年2月～2015年2月我院根据最新的罗马III诊断标准收治的146例IBS患者,随机分为对照组和实验组；对照组服用双歧三联活菌4w,实验组在服用双歧三联活菌的基础上,同时服用复方消化酶4w。结果两组治疗后IBS症状积分均显著低于治疗前(<0.05)；实验组的治疗后IBS症状积分显著低于对照组治疗后IBS症状积分(<0.05)；实验组的总有效率显著高于对照组(<0.05)。两组患者治疗后排便次数及排便时间、腹痛次数均较治疗前降低,治疗后实验组排便次数、排便时间及腹痛次数较对照组显著降低,两组之间的差异具有统计学意义(=3.579,2.037,6.192,<0.05)。结论复方消化酶并双歧三联活菌治疗IBS患者有较好的临床疗效,同时可以改善胃肠道运动功能。“,”Objective To study the influences of the digestive enzymes and bifid triple viable on bowel movement and efficacy in irritable bowel syndrome (IBS)patients.Methods Acorrding to the latest Rome III criteria for the diagnosis of IBS patients,selecting the 146 cases of IBS patients in my hospital during February,2013 to February 2015,they were randomly divided into control group and experimental group;Control group taking the bifid triple viable for 4 weeks,the experimental group on the basis of taking the bifid triple viable,took the compound enzymes at the same time for 4 weeks.Results The two groups after treatment of IBS symptoms score were significantly lower than before treatment ( <0.05);The experimental group after the treatment of IBS symptoms significantly lower than the control group after treatment of IBS symptoms integral( <0.05);The experimental group total effective rate is significantly higher than the control group ( <0.05).The number of defecation and defecation time,the number of abdominal pain after treatment were lower than before,the number of defecation and defecation time,the number of abdominal pain of the experimental group was significantly lower than the control group,and the difference between the two groups have statistical significance ( =3.579,2.037,3.579, <0.05). Conclusion Compound enzymes and the the bifid triple viable has good clinical efficacy on the treatment of IBS patients,at the same time can improve the gastrointestinal motor function.